Wealthfront Advisers’s Organon & Co OGN Stock Holding History

Wealthfront Advisers’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,906	Closed	-$209K	–	699
2021 Q2	$209K	Buy	+6,906	New	+$227K	﹤0.01%	613

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealthfront Advisers's OGN Position: Q3 2021 in Review

Wealthfront Advisers sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 6,906 shares — an estimated $209K sold.

Wealthfront Advisers first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $209K in Q2 2021. 928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

Wealthfront Advisers reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
Wealthfront Advisers sold 6,906 Organon & Co shares in Q3 2021, an estimated $209K.
Wealthfront Advisers first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
Wealthfront Advisers's Organon & Co position peaked at $209K in Q2 2021.
928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on Wealthfront Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.